NL-OMON56633
Not yet recruiting
Not Applicable
Clinical evaluation of Contrast Enhanced Breast CT in women recalled from screening due to calcifications - CEBCT-Calcs
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- Radboud Universitair Medisch Centrum
- Enrollment
- 539
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Women 50 to 75 years old
- •\- Recalled from screening due to calcifications
- •\- Planned to go for stereotactic biopsy
Exclusion Criteria
- •\- Women with prior breast cancer
- •\- Women who are very frail and unable to cooperate
- •\- Women who cannot give informed consent
- •\- Contraindication of iodine contrast (i.e., contrast allergy, renal function
- •impairment (GFR \>\=60 mL/min/1\.73m2\))
- •\- Contraindication for irradiation (i.e., genetic mutation that predispose to
- •breast cancer)
- •\- Male subjects
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical evaluation of Contrast Enhanced Breast CT to improve Staging and treatment follow up in women with breast cancerbreast cancerMamma carcinoma10006291NL-OMON54169Radboud Universitair Medisch Centrum413
Completed
Not Applicable
Clinical study of contrast-enhanced mammography on pre-operative diagnosis of breast cancerBreast cancerJPRN-UMIN000026800Dokkyo Medical University Koshigaya Hospital50
Completed
Not Applicable
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional studybreast cancerJPRN-UMIN000005029Grants for Scientific Research from the Expenses for Health and Welfare Program (17-7) from the Ministry of Health, Labour and Welfare of Japan300
Not yet recruiting
Not Applicable
Evaluation of Contrast Enhanced Breast CT for Diagnosis and Staging of Breast CancerBreast CancerNCT05404087Radboud University Medical Center413
Active, not recruiting
Phase 1
Evaluation of the use of contrast agent in mammography to improve the specificity of breast cancer diagnosisPatients with breast lesions undergoing further examinationMedDRA version: 20.0Level: PTClassification code 10061021Term: Breast disorderSystem Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-000326-22-ITISTITUTO EUROPEO DI ONCOLOGIA170